AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $136,000 | -31.3% | 12,100 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $198,000 | -7.9% | 12,100 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $215,000 | +33.5% | 12,100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $161,000 | +18.4% | 12,100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $136,000 | -46.0% | 12,100 | -2.4% | 0.00% | -50.0% |
| Q3 2019 | $252,000 | -65.0% | 12,400 | -50.0% | 0.00% | -50.0% |
| Q2 2019 | $720,000 | -24.1% | 24,800 | +63.2% | 0.00% | -33.3% |
| Q1 2019 | $948,000 | +114.0% | 15,200 | +22.6% | 0.01% | +100.0% |
| Q4 2018 | $443,000 | -53.3% | 12,400 | -18.4% | 0.00% | -50.0% |
| Q3 2018 | $948,000 | -9.5% | 15,200 | -2.6% | 0.01% | -14.3% |
| Q2 2018 | $1,048,000 | +25.1% | 15,600 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $838,000 | +1.0% | 15,600 | -1.9% | 0.01% | 0.0% |
| Q4 2017 | $830,000 | 0.0% | 15,900 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $830,000 | -2.5% | 15,900 | 0.0% | 0.01% | -14.3% |
| Q2 2017 | $851,000 | +17.7% | 15,900 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $723,000 | +11.2% | 15,900 | -7.6% | 0.01% | 0.0% |
| Q4 2016 | $650,000 | +8.5% | 17,200 | +8.2% | 0.01% | 0.0% |
| Q3 2016 | $599,000 | +109.4% | 15,900 | 0.0% | 0.01% | +133.3% |
| Q2 2016 | $286,000 | +74.4% | 15,900 | +17.8% | 0.00% | +50.0% |
| Q1 2016 | $164,000 | -48.8% | 13,500 | +3.1% | 0.00% | -50.0% |
| Q4 2015 | $320,000 | +41.0% | 13,100 | +2.3% | 0.00% | +33.3% |
| Q3 2015 | $227,000 | +9.7% | 12,800 | +9.4% | 0.00% | +50.0% |
| Q2 2015 | $207,000 | -41.5% | 11,700 | +3.5% | 0.00% | -50.0% |
| Q1 2015 | $354,000 | – | 11,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|